Home Coreceptor Usage and Biological Phenotypes of HIV-1 Isolates
Article
Licensed
Unlicensed Requires Authentication

Coreceptor Usage and Biological Phenotypes of HIV-1 Isolates

  • Tonie Cilliers and Lynn Morris
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 9

Abstract

The discovery of chemokine receptors as HIV-1 entry molecules or “coreceptors” has lead to a greater understanding of how HIV-1 infects human cells. This has provided insight into the biological properties of HIV-1 isolates and unravelled the meaning of the syncytium-inducing and non-syncytium-inducing phenotypes. Understanding how HIV-1 exploits these coreceptors has given way to novel approaches to controlling HIV. As a result a new class of drugs has emerged that are being tested to prevent virus infection and to act as an alternative, or adjunct, to existing anti-retroviral drugs for HIV-infected individuals.

:
Published Online: 2005-06-01
Published in Print: 2002-09-24

Copyright (c) 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Addressing Diseases in Africa
  2. Tuberculosis: The Struggle Continues
  3. Genetic Susceptibility to Tuberculosis
  4. Protein Expression in Mycobacterium tuberculosis Differs with Growth Stage and Strain Type
  5. Molecular Detection of Early Appearance of Drug Resistance during Mycobacterium tuberculosis Infection
  6. Prevalence of Anti-mycolic Acid Antibodies in Patients with Pulmonary Tuberculosis Co-infected with HIV
  7. Reduction of the Rate of False-Positive Cultures of Mycobacterium tuberculosis in a Laboratory with a High Culture Positivity Rate
  8. Enhanced Immune Response in Mycobacterium bovis Bacille Calmette Guerin (BCG)-Infected IL-10-Deficient Mice
  9. The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes
  10. Coreceptor Usage and Biological Phenotypes of HIV-1 Isolates
  11. Overcoming Multidrug Resistance in Taxane Chemotherapy
  12. Accurate Microsatellite Typing and Inter-study Comparison: Pitfalls and Solutions Using Interferon-γ (IFNG) and Natural Resistance-associated Mocrophage Protein 2 (NRAMP2) Genes as Examples
  13. Synergism between Urinary Prothrombin Fragment 1 and Urine: A Comparison of Inhibitory Activities in Stone-Prone and Stone-Free Population Groups
  14. Immunoglobulin G and Subclass Responses to Plasmodium falciparum Antigens: A Study in Highly Exposed Cameroonians
  15. Infrequent Somatic Deletion of the 5' Region of the COL1A2 Gene in Oesophageal Squamous Cell Cancer Patients
  16. The Quantitative Analysis of Zearalenone and Its Derivatives in Plasma of Patients with Breast and Cervical Cancer
  17. Genetic Polymorphism of Cytochrome P450 1A1 (CYP1A1) and Glutathione Transferases (M1, T1 and P1) among Africans
  18. Meetings and Awards
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.160/html
Scroll to top button